196 related articles for article (PubMed ID: 17934094)
21. Rheumatoid arthritis and ankylosing spondylitis - pathology of acute inflammation.
Appel H; Loddenkemper C; Miossec P
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S15-9. PubMed ID: 19822040
[TBL] [Abstract][Full Text] [Related]
22. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.
Kenna TJ; Davidson SI; Duan R; Bradbury LA; McFarlane J; Smith M; Weedon H; Street S; Thomas R; Thomas GP; Brown MA
Arthritis Rheum; 2012 May; 64(5):1420-9. PubMed ID: 22144400
[TBL] [Abstract][Full Text] [Related]
23. Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics.
Cantini F; Nannini C; Niccoli L; Petrone L; Ippolito G; Goletti D
Mediators Inflamm; 2017; 2017():8909834. PubMed ID: 28659665
[TBL] [Abstract][Full Text] [Related]
24. Outcome measures of disease activity in inflammatory arthritis.
Brown GA; Cotton A; Guinto J; Sharma A; Ciurtin C
Br J Hosp Med (Lond); 2017 Aug; 78(8):432-437. PubMed ID: 28783399
[TBL] [Abstract][Full Text] [Related]
25. Emerging role for NK cells in the pathogenesis of inflammatory arthropathies.
Conigliaro P; Scrivo R; Valesini G; Perricone R
Autoimmun Rev; 2011 Aug; 10(10):577-81. PubMed ID: 21536152
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.
Cugno M; Gualtierotti R; Meroni PL; Marzano AV
Clin Rev Allergy Immunol; 2018 Apr; 54(2):269-281. PubMed ID: 28735350
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions?
Berthelot JM; Le Goff B; Maugars Y
Arthritis Res Ther; 2019 Nov; 21(1):239. PubMed ID: 31722720
[TBL] [Abstract][Full Text] [Related]
28. Psoriatic arthritis: clinical spectrum and diagnostic procedures.
Kleinert S; Feuchtenberger M; Kneitz C; Tony HP
Clin Dermatol; 2007; 25(6):519-23. PubMed ID: 18021887
[TBL] [Abstract][Full Text] [Related]
29. Problems with definitions of disease patterns in psoriatic arthritis.
Le Goff P
J Rheumatol; 2006 Jan; 33(1):198-9; author reply 199. PubMed ID: 16395770
[No Abstract] [Full Text] [Related]
30. [RETROSPECTIVE DATA ANALYSIS OF THE PATIENTS WITH INFLAMMATORY JOINT DISEASES TREATED WITH GOLIMUMAB IN CROATIA].
Anić B; Babić-Naglić Ð; Grazio S; Kehler T; Kaliterna DM; Radoncić KM; Morović-Vergles J; Novak S; Prus V; Vlak T; Baresić M
Reumatizam; 2015; 62(1):12-9. PubMed ID: 27024887
[TBL] [Abstract][Full Text] [Related]
31. Influence of RANKL inhibition on immune system in the treatment of bone diseases.
Fouque-Aubert A; Chapurlat R
Joint Bone Spine; 2008 Jan; 75(1):5-10. PubMed ID: 17920324
[TBL] [Abstract][Full Text] [Related]
32. Extra-articular manifestations.
Mielants H; Van den Bosch F
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S56-61. PubMed ID: 19822047
[TBL] [Abstract][Full Text] [Related]
33. [Incidence of hepatitis-associated antigen (Australia antigen) in chronic inflammatory joint disease].
Lehmann H; Josenhans G; Schlaak M
Dtsch Med Wochenschr; 1973 Jul; 98(30):1430-1. PubMed ID: 4198190
[No Abstract] [Full Text] [Related]
34. Bone remodeling in psoriasis and psoriatic arthritis: an update.
Paine A; Ritchlin C
Curr Opin Rheumatol; 2016 Jan; 28(1):66-75. PubMed ID: 26555451
[TBL] [Abstract][Full Text] [Related]
35. Bone morphogenetic protein signaling in joint homeostasis and disease.
Lories RJ; Luyten FP
Cytokine Growth Factor Rev; 2005 Jun; 16(3):287-98. PubMed ID: 15993360
[TBL] [Abstract][Full Text] [Related]
36. Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis.
Taylor WJ; Zmierczak HG; Helliwell PS
J Rheumatol; 2005 Jun; 32(6):974-7. PubMed ID: 15940753
[No Abstract] [Full Text] [Related]
37. The seronegative spondyloarthropathies.
Kettering JM; Towers JD; Rubin DA
Semin Roentgenol; 1996 Jul; 31(3):220-8. PubMed ID: 8827866
[TBL] [Abstract][Full Text] [Related]
38. From skin to bone: translational perspectives on psoriatic disease.
Ritchlin CT
J Rheumatol; 2008 Jul; 35(7):1434-7. PubMed ID: 18609740
[TBL] [Abstract][Full Text] [Related]
39. Spondyloarthropathies and psoriatic arthritis in children.
Burgos-Vargas R
Curr Opin Rheumatol; 1993 Sep; 5(5):634-43. PubMed ID: 8398612
[TBL] [Abstract][Full Text] [Related]
40. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
Orsolini G; Bertoldi I; Rossini M
Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
